Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone?
Musto
P
P
Falcone
A
A
Carotenuto
M
M
Catalano
L
L
Cennamo
A
A
Rotoli
B
B
D000753:Anemia, Refractory / Q000628:therapy*; D000756:Anemia, Sideroblastic / Q000628:therapy*; D001803:Blood Transfusion; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007958:Leukocyte Count; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy*
D006454:Hemoglobins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor